Traumatic brain injuries (TBIs) are a serious public health issue worldwide with increased mortality as well as severe disabilities and injuries caused by falls and road accidents. Unfortunately, there is no approved therapy for TBIs, and bladder dysfunction is a striking symptom. Accordingly, we attempted to analyze bladder dysfunction and voiding efficiency in rats with a TBI at different time-course intervals. Time-dependent analyses were scheduled from the next day until four weeks after a TBI. Experimental animals were grouped and analyzed under the above conditions. Cystometric measurements were used for this analysis and were further elaborated as external urethral sphincter electromyographic (EUS-EMG) activity and cystometrogram (CMG) measurements. Moreover, magnetic resonance imaging (MRI) studies were conducted to investigate secondary injury progression in TBI rats, and results were compared to normal control (NC) rats. Results of EUS-EMG revealed that the burst period, active period, and silent period in TBI rats were drastically reduced compared to NC rats, but they increased later and reached a stagnant phase. Likewise, in CMG measurements, bladder function, the voided volume, and voiding efficiency decreased immediately after the TBI, and other parameters like the volume threshold, inter-contraction interval, and residual volume drastically increased. Later, those levels changed, and all observed results were compared to NC rats. MRI results revealed the prevalence of cerebral edema and the progression of secondary injury. All of the above-stated results of the experiments were extensively substantiated. Thus, these innovative findings of our study model will surely pave the way for new therapeutic interventions for TBI treatment and prominently highlight their applications in the field of neuroscience in the future.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895874PMC
http://dx.doi.org/10.3390/brainsci9110325DOI Listing

Publication Analysis

Top Keywords

cystometric measurements
8
traumatic brain
8
bladder dysfunction
8
voiding efficiency
8
cmg measurements
8
secondary injury
8
tbi rats
8
compared rats
8
rats
7
tbi
6

Similar Publications

Despite the close and clinically confirmed association between depression and overactive bladder, it remains unclear whether this affective disorder is a factor causing overactive bladder or whether overactive bladder is a specific symptom of psychosomatic disorders. This study examined the effects of repeated corticosterone administration on the occurrence of symptoms associated with depression and overactive bladder. Additionally, we examined whether administering TC-G 1008, an antidepressant that selectively activates the GPR39 receptor, could alleviate corticosterone-induced depression-like behavior and detrusor overactivity-related changes in cystometric measurements.

View Article and Find Full Text PDF

Background: The purpose of this article was to assess the recoverability of bladder, in a subset of patients with uremia, planned for live-donor kidney transplantation.

Methods: Patients referred to the Voiding Dysfunction Unit for evaluation, prior to transplantation, were included in this study during the period 2004 to 2008 in a single institution with a track record in live-donor transplantation. Defunctionalized bladder was defined as patients with complete anuria or oliguria for at least 6 months.

View Article and Find Full Text PDF

Introduction: COVID-19-associated cystitis (CAC) may arise following a COVID-19 infection and is characterized by the development of novel or worsening overactive bladder (OAB). CAC is possibly associated with bladder mucosal damage and the release of pro-inflammatory cytokines, resulting in inflammation and fibrosis of the bladder wall. Amniotic membrane (AM) has been shown to possess anti-inflammatory and anti-fibrotic properties and might potentially be beneficial for CAC.

View Article and Find Full Text PDF
Article Synopsis
  • Overactive bladder (OAB) is frequently observed in patients with multiple sclerosis, prompting the study to explore treatment options.* -
  • The study involved 45 participants with MS who were assigned to three groups: one receiving biofeedback and pelvic floor exercises, another receiving transcranial magnetic stimulation and pelvic floor exercises, and a control group with only pelvic floor exercises.* -
  • Both treatment methods showed improvement in bladder function, but there was no significant difference in outcomes between the groups; however, biofeedback was noted to be more effective than transcranial magnetic stimulation.*
View Article and Find Full Text PDF
Article Synopsis
  • * Various tests including the forced swim test, cystometry, and biochemical analyses were conducted to evaluate the impact of a 7-day TCS administration on bladder function and depressive behaviors.
  • * Results indicate that TCS improved bladder overactivity and reversed depressive signs, suggesting a potential link between the orexin system and both urinary bladder function and depression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!